MSGE:NYSEMadison Square Garden Entertainment Corp. Analysis
Data as of 2026-04-18 - not real-time
$62.78
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Madison Square Garden Entertainment is trading at $62.78, just below its 30‑day resistance of $63.14 and above the 20‑day SMA of $59.27, while the MACD shows a bullish divergence (line $0.86 above signal $0.48) and RSI sits at 63, indicating momentum but no extreme overbought condition. DCF analysis suggests a fair value of $71.08, implying roughly a 10% upside, and BTIG’s recent buy coverage with a median 12‑month price target of $69 reinforces the upside thesis. Fundamentally, revenue grew 13% YoY to $1.01 B with solid operating margins (35.7%) and a modest profit margin (5.1%), yet the balance sheet is heavily leveraged (debt‑to‑equity > 3,000%) and ROE is low at 2.2%, limiting upside from earnings growth alone. The stock carries no dividend, exhibits moderate 30‑day volatility (≈28%) and a beta near 0.9, placing it in a typical consumer‑cyclical risk profile, while liquidity remains adequate given a $3 B market cap and stable volume. Overall, the combination of technical strength, a DCF‑derived discount, and analyst support suggests a near‑term buying opportunity, but the high leverage and valuation multiples (PE ≈ 58, PB ≈ 82) warrant caution for long‑term investors.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and RSI indicating upward momentum
- Price trading near support with limited downside to $54.30
- Analyst buy rating and upside to DCF fair value
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth of 13% and strong operating margins
- DCF fair value providing ~10% upside
- Stable volume and adequate market cap supporting liquidity
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High leverage and low ROE limiting earnings sustainability
- Elevated valuation multiples (PE, PB) relative to peers
- Consumer‑cyclical exposure to economic cycles
Key Metrics & Analysis
Financial Health
Revenue Growth12.90%
Profit Margin5.12%
P/E Ratio57.6
ROE224.08%
ROA5.93%
Debt/Equity3319.62
P/B Ratio82.4
Op. Cash Flow$214.0M
Free Cash Flow$189.8M
Technical Analysis
TrendNeutral
RSI63.2
Support$54.30
Resistance$63.14
MA 20$59.27
MA 50$59.76
MA 200$49.85
MACDBullish
VolumeStable
Fear & Greed Index90.21
Valuation
Fair Value$71.08
Target Price$69.13
Upside/Downside10.11%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.92
Volatility28.43%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
MSGM
Motorsport Games Inc.
STOCKMSEX
Middlesex Water Company
STOCKMSBIP
Midland States Bancorp, Inc. - Depositary Shares Each Representing a 1/40th Interest in a Share of 7.750% Fixed-Rate Reset Non-Cumulative Perpetual Preferred St
STOCKMSBI
Midland States Bancorp, Inc.
STOCKMSAI
MultiSensor AI Holdings, Inc.
STOCKMRX
Marex Group plc
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.